Physician

Hematology

Dr. Stephen P. Kahanic, MD

Doctor Stephen P. Kahanic, MD is an expert in the field of Hematology. He researched medicine at Case Western Reserve University School of Medicine. Stephen P. Kahanic is a published MD. He published 3 publications, including: 'RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer.' Stephen Kahanic is registered with Medicare and accepts Medicare payments.

Publications

RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast Cancer.
Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients wi...
Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment G...

Schools

Case Western Reserve University School of Medicine
University Iowa Hosps and Clinics

Procedures Preformed

Thoracentesis

Conditions Treated

Acute Leukemia
Adrenal Gland Cancer
Anal and Rectal Cancer
Anemia
View All

Doctors Specialties

Medical Oncology
Oncology
Hematology

Accepted Insurances

Education

University of Iowa Hospitals and Clinics
Case Western Reserve University School of Medicine

Drug Facts

NPI NUMBER		1962474155
NPPES Provider LastName		KAHANIC
NPPES Provider FirstName		STEPHEN
NPPES Provider ZIPCode		511011733
NPPES Provider State		IA
Specialty Description		Hematology/Oncology
Total Claim Count		221.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1962474155
Last Name Of The Provider	KAHANIC
First Name Of The Provider	STEPHEN
View All

Similar Doctors

Dr. John C. Michalak, MD

This Doctor is OpenDoctor Recommended.

This doctor has more publications